This nonrandomized clinical trial examines the safety and efficacy of oral upadacitinib in the treatment of patients with severe immune checkpoint inhibitor–related dermatitis.
Get the latest international news and world events from around the world.
Rare footage of humpback whale birth captured on drone video: “A remarkable moment”
Forrest was joined by members of ORRCA’s team, who continued to monitor the mother and calf over several hours, “collecting observations during the critical first hours of the calf’s life,” the organization said on social media.
The footage is believed to be only the fourth complete humpback whale birth ever recorded on film anywhere in the world and the first-ever captured by drone.
“Every observation like this has the potential to expand our understanding of humpback whale reproduction, maternal behaviour and the earliest stages of a calf’s life,” ORRCA said.
Can We Defeat Human Aging?
For all of human history, death has been the one certainty.
That certainty is now being challenged.
The biggest names in longevity research believe aging can be slowed, reversed, and one day eliminated. AI researchers think biology is simply another puzzle waiting to be solved. Together, they may be building the technology that changes civilization forever.
But extending life isn’t the real story.
The real story is what happens when humanity no longer has an expiration date.
This is the science, the debate, and the future of defeating aging.
MicroRNA-based gene therapy to treat ALS
A single IV injection of a microRNA-based biologic suppressed production of the mutant SOD1 protein that causes amyotrophic lateral sclerosis (ALS); delayed disease onset by 60 days; and extended lifespan by 100 days, more than triple the average survival time, in mice models of the disease.
The gene therapy, delivered via adeno-associated virus (AAV) vector, preserved motor neurons and maintained neuromuscular connections in treated animals, which translated into improved muscle and respiratory function, motor performance, and lifespan in pre-clinical studies. These findings, published in Nature Communications, have the potential for clinical application in patients with SOD1-caused ALS, as well as other neurodegenerative diseases caused by toxic, gain-of-function gene mutations.
“These therapeutic benefits, from a single IV injection, are unprecedented among gene therapy approaches in this mouse model,” said the senior author. “No other studies have been able to achieve this kind of survival extension. This makes us very optimistic that our approach could have a meaningful impact for patients suffering from this horrible disease and warrants further clinical evaluation.”
Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment
Resistance to cancer drugs is a complex phenomenon that poses a significant challenge in the treatment of various malignancies. This review comprehensively explores cancer resistance mechanisms and discusses emerging strategies and modalities to overcome this obstacle. Many factors contribute to cancer resistance, including genetic mutations, activation of alternative signaling pathways, and alterations in the tumor microenvironment. Innovative approaches, such as targeted protein degradation, immunotherapy combinations, precision medicine, and novel drug delivery systems, hold promise for improving treatment outcomes. Understanding the intricacies of cancer resistance and leveraging innovative modalities are essential for advancing cancer therapy.
How muscle cells grow and stay healthy
Biophysicists unraveled a mystery of how muscles form at the molecular level and how they maintain their function. Nature Communications published the discovery, which may help in the design of treatments for muscle diseases such as dilated cardiomyopathy, one of the leading causes of heart failure.
“We’ve made a fundamental advance in understanding how the cellular cytoskeleton is assembled, especially in muscle cells,” says the senior author of the study.
The researchers upended a model relied on for more than four decades to explain how filaments of actin, a protein vital to cellular movement and other functions, form and maintain their length.
Cerebral Edema in Traumatic Brain Injury
Cerebral edema is the abnormal accumulation of fluid in any of the tissue compartments of the cerebral parenchyma. It remains a significant challenge in neurotrauma care because it contributes to secondary brain injury, affecting prognosis. This review analyzes the recent literature, including foundational studies, to describe the mechanisms of distinct types of cerebral edema following traumatic brain injury (TBI). Emerging concepts, such as the role of the glymphatic system and heme-derived inflammasomes, offer new insights into new types of edemas, differentiated by pathogenesis and potential treatments. Recent advancements in understanding these molecular mechanisms can improve therapeutic strategies, facilitating a better approach in the era of precision and personalized medicine.
Should Brain MRI Screening Expand in Metastatic Breast Cancer?
Brain metastases are a major clinical concern in metastatic breast cancer, particularly in HER2-positive and triple-negative disease. Over time, approximately 25% to 50% of patients with these subtypes develop brain metastases, which can lead to neurological disability, cognitive impairment, reduced independence, and substantial deterioration in quality of life.
Despite this risk, routine brain imaging is not consistently recommended for patients without neurological symptoms.
An article published in The Breast argues that it may be time to reconsider this symptom-directed approach. Sarah Sammons, Nayan Lamba, and Nancy U. Lin outline a growing case for brain MRI screening in selected patients with metastatic breast cancer, while also acknowledging that survival benefit, optimal timing, cost-effectiveness, and potential harms remain uncertain.
Combination of Radiotherapy and Immunotherapy in Advanced NonSmall Cell Lung Cancer
Cerebral edema is the abnormal accumulation of fluid in any of the tissue compartments of the cerebral parenchyma. It remains a significant challenge in neurotrauma care because it contributes to secondary brain injury, affecting prognosis. This review analyzes the recent literature, including foundational studies, to describe the mechanisms of distinct types of cerebral edema following traumatic brain injury (TBI). Emerging concepts, such as the role of the glymphatic system and heme-derived inflammasomes, offer new insights into new types of edemas, differentiated by pathogenesis and potential treatments. Recent advancements in understanding these molecular mechanisms can improve therapeutic strategies, facilitating a better approach in the era of precision and personalized medicine. Although there has been notable progress, a proposal to customize treatments for diverse types of edemas is necessary to improve outcomes following traumatic brain injury. In this review, we describe the current subtypes of post-traumatic brain edemas and link them to a specific management approach.